Pfizer, Mphasis, Johnson Controls-Hitachi and More Trading Ex-Dividend on July 09, 2025

Today, July 9, 2025, several notable companies, including Pfizer, Mphasis, Johnson Controls-Hitachi, SML Isuzu, and Sundaram Finance, are trading ex-dividend. This means the shares will trade without the value of the upcoming dividend payouts.

How Eligibility Was Decided

The record date for determining eligible shareholders was set for today. As per T+1 settlement, investors had to purchase shares no later than July 8 to qualify for the dividends.

Dividend Payout Details

Pfizer Limited

• Recommended a final dividend of ₹35 per share (350%) for FY25.
• Announced special dividends of ₹100 per share (1000%) to mark its 75th anniversary and ₹30 per share (300%) due to a property sale gain.
• Total payout: ₹165 per share (1650%).

Mphasis

• Recommended a dividend of ₹57 per share for the year ending March 31, 2025.
• Subject to shareholder approval at the upcoming AGM.

Johnson Controls-Hitachi Air Conditioning

• announced an interim dividend of ₹36 per share (360%) for FY26.
• Payment scheduled on or before July 24, 2025.

SML Isuzu

• Announced a final dividend of ₹18 per share (180%) for FY24-25.

Sundaram Finance

• Proposed a final dividend of ₹21 per share (210%) for FY25.
• Along with the interim dividend of ₹14, the total dividend for the year is ₹35 per share (350%).

Other Companies Trading Ex-Dividend

• Elegant Marbles & Grani Industries Ltd: Final dividend ₹1.00 per share
• Kabra Extrusiontechnik Ltd: Final dividend ₹2.50 per share
• S.J.S. Enterprises Ltd: Final dividend ₹2.50 per share

Stocks Trading Ex-Dividend Today

Read More: Pfizer Dividend of ₹165/Share: Ex-Date Today, July 9 – What You’ll Earn for 50 Shares? 

Conclusion

These dividend announcements show that companies across sectors are rewarding shareholders for their continued support. Investors interested in dividends should watch ex-dividend dates carefully to ensure eligibility for payouts.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.